COMMUNIQUÉS West-GlobeNewswire

Scythian Biosciences Announces 4-For-1 Stock Split and Appointment of Vic Neufeld as New Chairman of the Board of Directors

12/03/2018 - 21:30

TORONTO, March 12, 2018 (GLOBE NEWSWIRE) -- Scythian Biosciences Corp. (the " Company " or “ Scythian ”) (TSXV:SCYB) (Frankfurt: 9SB ) (OTC – Nasdaq Intl:SCCYF) announces that, further to its press release on March 9, [...]

Radius Health to Present at ENDO 2018 Including Results of the ACTIVExtend BMD Responder Analysis for TYMLOS™ (abaloparatide) Injection

12/03/2018 - 21:30

WALTHAM, Mass., March 12, 2018 (GLOBE NEWSWIRE) -- Radius Health, Inc. (Nasdaq: RDUS ) a science-driven fully integrated biopharmaceutical company that is committed to developing and commercializing innovative endocrine [...]

Vericel to Host Analyst and Investor Day on April 11, 2018

12/03/2018 - 21:30

CAMBRIDGE, Mass., March 12, 2018 (GLOBE NEWSWIRE) -- Vericel Corporation (NASDAQ: VCEL ), a leader in advanced cell therapies for the sports medicine and severe burn care markets, today announced that it will host an [...]

Teligent, Inc. to Hold Conference Call for Fourth Quarter 2017 Results

12/03/2018 - 21:30

BUENA, N.J., March 12, 2018 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ: TLGT ), a New Jersey-based specialty generic pharmaceutical company, announced the Company will hold a conference call at 4:30pm ET on Thursday [...]

VBI Vaccines Announces Voluntary Delisting from the Toronto Stock Exchange

12/03/2018 - 21:15

CAMBRIDGE, Mass., March 12, 2018 (GLOBE NEWSWIRE) -- VBI Vaccines Inc. ("VBI" or the "Company") (Nasdaq: VBIV ) (TSX: VBV ), a commercial-stage biopharmaceutical company developing next-generation infectious disease and [...]

Agile Therapeutics Reports Fourth Quarter and Full Year 2017 Financial Results

12/03/2018 - 21:15

PRINCETON, N.J., March 12, 2018 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX ), a women's healthcare company, today reported financial results for the three months and year ended December 31, 2017 and [...]

Amphastar Pharmaceuticals Reports Financial Results for the Three Months and Fiscal Year Ended December 31, 2017

12/03/2018 - 21:05

RANCHO CUCAMONGA, Calif., March 12, 2018 (GLOBE NEWSWIRE) -- Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH ) (“Amphastar” or the “Company”) today reported results for the three months and fiscal year ended December 31, [...]

Proteostasis Therapeutics Announces FDA Grants Breakthrough Therapy Designation for PTI-428 in Cystic Fibrosis

12/03/2018 - 21:05

CAMBRIDGE, Mass., March 12, 2018 (GLOBE NEWSWIRE) -- Proteostasis Therapeutics, Inc. (NASDAQ: PTI ), a clinical stage biopharmaceutical company dedicated to the discovery and development of groundbreaking therapies to [...]

Prothena to Present a Broad Range of Scientific and Health Outcomes Data at the 16th International Symposium on Amyloidosis

12/03/2018 - 21:05

DUBLIN, Ireland, March 12, 2018 (GLOBE NEWSWIRE) -- Prothena Corporation plc (Nasdaq: PRTA ), a late-stage clinical biotechnology company focused on the discovery, development and commercialization of novel therapies in [...]

Crinetics Pharmaceuticals Announces Upcoming Presentations at ENDO 2018

12/03/2018 - 21:05

SAN DIEGO, March 12, 2018 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals, Inc., a rare disease therapeutics company focused on endocrine disorders and endocrine-related cancers, today announced an oral presentation and [...]

Aquinox Pharmaceuticals Announces Year End 2017 Financial Results

12/03/2018 - 21:05

VANCOUVER, British Columbia, March 12, 2018 (GLOBE NEWSWIRE) -- Aquinox Pharmaceuticals , Inc. (" Aquinox ") (NASDAQ: AQXP ), a clinical-stage pharmaceutical company discovering and developing novel drug candidates to [...]

G1 Therapeutics Announces Closing of Offering of Common Stock

12/03/2018 - 21:05

RESEARCH TRIANGLE PARK, N.C., March 12, 2018 (GLOBE NEWSWIRE) -- G1 Therapeutics, Inc. (Nasdaq: GTHX ), a clinical-stage oncology company, today announced the closing of an underwritten public offering of 3,910,000 [...]

Kura Oncology Provides Regulatory Update on Tipifarnib and Reports Fourth Quarter and Full Year 2017 Financial Results

12/03/2018 - 21:05

– Company plans to initiate registration-directed trial of tipifarnib in second half of 2018 following recent end of Phase 2 meeting with the FDA – – Single-arm trial to enroll at least 59 recurrent or metastatic HRAS [...]

Avid Bioservices Reports Financial Results for Third Quarter of Fiscal Year 2018 and Recent Developments

12/03/2018 - 21:05

Company Remains on Target for Full Year Revenue of $50.0 - $55.0 Million Intensified Business Development Effort Results in New Customer Contract and Strengthened Backlog TUSTIN, Calif., March 12, 2018 (GLOBE NEWSWIRE [...]

Tabula Rasa HealthCare Announces Fourth Quarter and Full Year 2017 Operating Results

12/03/2018 - 21:05

2017 Revenue of $134.5 million, growth of 43%; 4Q 2017 Revenue of $43.9 million, growth of 61% Provides initial 2018 financial outlook MOORESTOWN, N.J., March 12, 2018 (GLOBE NEWSWIRE) -- Tabula Rasa HealthCare, Inc. (“ [...]

Positive Phase 1/2 Results of AKCEA-APOCIII-LRx Presented at American College of Cardiology Annual Scientific Session & Expo

12/03/2018 - 21:05

CAMBRIDGE, Mass. and CARLSBAD, Calif. , March 12, 2018 (GLOBE NEWSWIRE) -- Akcea Therapeutics, Inc. (NASDAQ: AKCA ), an affiliate of Ionis Pharmaceuticals, Inc. (NASDAQ: IONS ), and Ionis Pharmaceuticals, Inc., today [...]

Rhythm Pharmaceuticals Reports Fourth Quarter and Full Year 2017 Financial Results

12/03/2018 - 21:01

-- Continuing Enrollment in Pivotal Phase 3 Clinical Trial of Setmelanotide in Pro-Opiomelanocortin (POMC) Deficiency Obesity; On Track to Complete Enrollment of 10 Patients in First Half of 2018 -- -- Enrolled First [...]

Iovance Biotherapeutics Reports Fourth Quarter and Full-Year 2017 Financial Results and Provides Corporate Update

12/03/2018 - 21:01

SAN CARLOS, Calif., March 12, 2018 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (NASDAQ: IOVA ), a biotechnology company developing novel cancer immunotherapies based on tumor-infiltrating lymphocyte (TIL) [...]

Adherium’s Directors Purchase Approximately 1.4 Million Shares on the Open Market

12/03/2018 - 18:38

SAN MATEO, Calif., March 12, 2018 (GLOBE NEWSWIRE) -- Adherium (ASX:ADR), a digital health company that improves medication adherence and patient outcomes, today announced that members of its Board of Directors recently [...]